-
-
-
-
-
-
-
Abbvie (ABBV) PT Raised to $273 at Canaccord
-
-
-
-
-
-
-
CNS Drug Delivery Technologies Are Reshaping Alzheimer’s and Biodefense Research
-
-
-
-
-
-
-
AbbVie to Acquire Arizona Manufacturing Facility, Further Strengthening Manufacturing Capabilities in the United States
-
-
-
-
-
-
-
AbbVie Completes Acquisition of Gilgamesh Pharmaceuticals' Bretisilocin
-
-
-
-
-
-
-
AbbVie Completes Acquisition of Capstan Therapeutics
-
-
-
-
-
-
-
AbbVie to Acquire Capstan Therapeutics, Further Strengthening Commitment to Transforming Patient Care in Immunology
-
-
-
-
-
-
-
AbbVie Reports Full-Year and Fourth-Quarter 2024 Financial Results
-
1,175,997 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

